{
 "name": "路迦生醫",
 "slug": "tw-6814",
 "aliases": [
  "路迦生醫股份有限公司",
  "LUKAS",
  "6814"
 ],
 "ticker": "6814",
 "industry": "生技醫療業",
 "website": "https://www.lukas-biomedical.com/",
 "summary": "路迦生醫（6814）是興櫃的生技醫療類股公司，2013 年成立，2020 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "路迦生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "LUKAS",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2020-12-31",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2013-12-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "唐稚超",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "劉朝安",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 418743710,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.lukas-biomedical.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：LuLym-T（Activated T Lymphocytes，ATL）",
   "value": "肝細胞癌術後輔助治療｜二期臨床招募中｜台灣",
   "unit": "",
   "as_of": "2026-09-01",
   "source": "https://clinicaltrials.gov/study/NCT05304481",
   "note": "NCT05304481；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "催化劑：LuLym-T",
   "value": "肝細胞癌二期試驗預估主要完成｜2027-12-31｜已公告",
   "unit": "",
   "as_of": "2026-09-01",
   "source": "https://clinicaltrials.gov/study/NCT05304481",
   "note": "NCT05304481；登錄預估日期，非藥證時程；全試驗預估2028-10-30超出18個月未列。"
  },
  {
   "claim": "主要產品：LuLym-T（記憶型T細胞）",
   "value": "自體記憶型T細胞治療技術；配合核准醫療機構提供特管細胞治療",
   "unit": "",
   "as_of": "2025-05-31",
   "source": "https://www.lukas-biomedical.com/investor_document-detail/74/",
   "note": "不是宣稱本產品已取得一般上市藥證。"
  },
  {
   "claim": "催化劑：LuKas_CAR-NK",
   "value": "提出專利申請｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2025-05-31",
   "source": "https://www.lukas-biomedical.com/investor_document-detail/74/",
   "note": "舊年報預估；未找到更新確認，不將未來計畫寫成已完成。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6814.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}